Pediatric Pulseless Arrest
Runal ShahPGY-3KDAH
Introduction•Kids are not tiny adults !!
• Hypotension (SBP) as per age▫Neonates (0-28 days) = <60▫Infants (1-12 months) = <70▫Children (1-10yr) = <70 + (2 x age in years)▫Children > 10yr = < 90
Introduction• Pulseless Arrest is the end result of
progressive▫Respiratory failure▫Shock
• Termed as HYPOXIC-ISCHEMIC ARREST.
• Respiratory failure and shock can be reversible if identified and treated early, if they progress to cardiac arrest – outcome is generally poor.
• Sudden death in young people is associated with underlying cardiac conditions.
Cardiac Arrest• Hypoxic/Asphyxial
▫Most common▫End result of tissue
hypoxia & acidosis▫Caused by
progressive respiratory failure/ shock
• Sudden Cardiac Arrest▫Less common▫Ventricular
Fibrillation/ Pulseless VT
▫Cardiac causes –HOCMAnomalous coronaryLong QT/ channelopathyMyocarditisDrug toxicityCommotio cordis
Pathway to Cardiac ArrestRespiratory
Failure Shock
Cardiopulmonary Failure
Sudden Ventricular Arrhythmia
Hypoxic / Asphyxial Arrest
Sudden Cardiac Arrest
Recognition ofCardiopulmonary Failure
• Airway – ▫Possible upper airway
obstruction• Circulation –
▫Bradycardia▫Delayed CRT (>2
seconds)▫Weak central pulses▫Absent peripheral
pulses▫Cool extremities▫Mottled or cyanotic
skin
▫Hypotension• Breathing –
▫Bradypnoea▫Irregular, ineffective
respirations• Disability –
▫Decreased level of consciousness
• Exposure – ▫Assess for obvious
bleeding▫Hypo/ Hyperthermia
Arrest Rhythms• Asystole & PEA – the most common initial
rhythms seen in both in-hospital and out-of-hospital pediatric cardiac arrest, especially in children <12 years of age.
• Survival & outcome of patients with VF or pulseless VT as initial rhythm are better.
6H’s 6T’sHypovolemia Tension Pneumothorax
Hypoxia TamponadeHydrogen ion (Acidosis) Toxins
Hypoglycemia Thrombosis (Pulmonary)
Hypo / Hyperkalemia Thrombosis (Coronary)
Hypothermia Trauma
Arrest Rhythms• Asystole
▫Cardiac standstill without discernable electrical activity.
▫Straight (flat) line on the ECG.▫Confirm clinically! Can be a loose ECG lead.
• PEA▫Any organized electrical activity with no
palpable pulse.▫Very slow PEA – “Agonal rhythm”• Low or high amplitude T waves• Prolonged PR, QT interval• AV dissociation, CHB or ventricular complexes
without P waves
Arrest Rhythms• Ventricular fibrillation (VF)
▫No organized rhythm & no coordinated contractions.
▫VF may be preceded by a brief period of VT.▫Can occur in Teens during sports activities.▫Undiagnosed cardiac abnormality/ channelopathy.
• Pulselesss Ventricular Tachycardia▫ Organized wide QRS complexes.▫ Usually of a brief duration before it deteriorates into
VF.▫ Torsades de pointes : Polymorphic VT• Prolonged QT, Dyselectrolemia, Drug toxicity
Key BLS component of PALS
Pediatric Advanced Life Support
• High quality CPR▫Adequate compression rate (100-120
compressions/min)
▫An adequate compression depth ≥ 1/3 of the AP diameter of the chest or
approximately 1 ½ inches [4 cm] in infants, approximately 2 inches [5 cm] in children
▫Allowing complete recoil of the chest after each compression,
▫Minimizing interruptions in compressions avoiding excessive ventilation
Algorithm• Epinephrine –
▫IV/IO = 0.01 mg/kg bolus (1:10,000)
▫ET = 0.1 mg/kg bolus (1:1000)
• Defibrillation –▫Initial dose = 2-4
J/kg▫Subsequent doses
= 4 J/kg or higher
(Max 10 J/kg)
New updates (2015) of PALS• In specific settings, when treating pediatric
patients with febrile illnesses, the use of restrictive volumes of isotonic crystalloid leads to improved survival.▫ This contrasts with traditional thinking that routine
aggressive volume resuscitation is beneficial.
• Routine use of atropine as a premedication for emergency tracheal intubation in non-neonates, specifically to prevent arrhythmias, is controversial.▫ Also, there are data to suggest that there is no
minimum dose required for atropine for this indication.
• If invasive arterial blood pressure monitoring is already in place, it may be used to adjust CPR to achieve specific blood pressure targets for children in cardiac arrest.
• Amiodarone or Lidocaine is an acceptable antiarrhythmic agent for shock-refractory pediatric VF and pulselessVT in children.
• Epinephrine continues to be recommended as a vasopressor in pediatric cardiac arrest.
• For pediatric patients with cardiac diagnoses and IHCA in settings with existing extracorporeal membrane oxygenation protocols, ECPR may be considered.
• Fever should be avoided when caring for comatose children with ROSC after OHCA.▫ A large randomized trial of therapeutic
hypothermia for children with OHCA showed no difference in outcomes whether a period of moderate therapeutic hypothermia (with temperature maintained at 32°C to 34°C) or the strict maintenance of normothermia (with temperature maintained 36°C to 37.5°C) was provided.
• Several intra-arrest and post–cardiac arrest clinical variables were examined for prognostic significance.
• No single variable was identified to be sufficiently reliable to predict outcomes. Therefore, caretakers should consider multiple factors in trying to predict outcomes during cardiac arrest and in the post-ROSC setting.
• After ROSC, fluids and vasoactive infusions should be used to maintain a systolic blood pressure above the fifth percentile for age.
• After ROSC, normoxemia should be targeted. When the necessary equipment is available, oxygen administration should be weaned to target an oxyhemoglobin saturation of 94% to 99%.
• Hypoxemia should be strictly avoided. Ideally, oxygen should be titrated to a value appropriate to the specific patient condition. Likewise, after ROSC, the child’s PaCO2 should be targeted to a level appropriate to each patient’s condition. Exposure to severe hypercapnia or hypocapnia should be avoided.
• References:• Chameides L, Samson RA, Schexnayder SM, Hazinski MF.
Pediatric advanced life support provider manual. Dallas, TX: American Heart Association. 2011.
• Care EC. Part 12 : Pediatric Advanced Life Support. 2015;2015:1–74.
Thank You…